According to the enterprise research app, Jiangsu Xianyu Biomaterials Co., Ltd. was recently established. The legal representative is Wang Health, with a registered capital of 160 million yuan. The business scope includes bio-based material manufacturing; bio-based material technology research and development; synthetic fiber manufacturing; sales of high-performance fibers and composite materials; and research and development of new material technology. According to enterprise research and equity penetration, the company is jointly owned by Jiangsu Sanlian New Materials Co., Ltd. and Huafeng Group Co., Ltd.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.